
Sign up to save your podcasts
Or
On Monday afternoon, Johnson & Johnson announced that it is pausing its clinical trials for the company’s COVID-19 vaccine candidate after a study participant became ill. Details are scarce, but Johnson & Johnson said in a press release that the patient had an “unexplained illness.” https://www.yahoo.com/lifestyle/johnson-johnsons-covid-19-vaccine-trial-pause-explained-experts-history-183902707.html https://www.naturalnews.com/2020-10-16-jj-halts-covid19-vaccine-trial-after-participant-illness.html
On Monday afternoon, Johnson & Johnson announced that it is pausing its clinical trials for the company’s COVID-19 vaccine candidate after a study participant became ill. Details are scarce, but Johnson & Johnson said in a press release that the patient had an “unexplained illness.” https://www.yahoo.com/lifestyle/johnson-johnsons-covid-19-vaccine-trial-pause-explained-experts-history-183902707.html https://www.naturalnews.com/2020-10-16-jj-halts-covid19-vaccine-trial-after-participant-illness.html